论文部分内容阅读
目的:研究银杏达莫联合血塞通注射液对急性脑梗死的治疗效果。方法:分成3组,分别为银杏达莫组、血塞通组、银杏达莫联合血塞通治疗组,每组40例。3组给予不同治疗后分别对治疗前及治疗后14、21 d对神经功能缺损及疗效进行评定。结果:银杏达莫组及血塞通组相比,在治疗后第14及21天,银杏达莫联合血塞通组神经功能缺损明显减轻(P<0.05),且疗效更明显(P<0.05)。结论:与银杏达莫组及血塞通组相比,银杏达莫与血塞通联合治疗可更加改善神经功能缺损(P<0.05),并能提高疗效,出血副作用无增加。
Objective: To study the therapeutic effect of Ginkgo biloba combined with Xuesaitong injection on acute cerebral infarction. Methods: The rats were divided into 3 groups: ginkgo dipyridamole group, Xuesaitong group and gingko Damo combined Xuesaitong group, 40 cases in each group. Three groups were given different treatment, respectively, before and after treatment, 14,21 d of neurological deficits and efficacy evaluation. Results: Compared with the Xuesaitong group, the neurological deficits of Gingsengdam combined Xuesaitong group were significantly reduced (P <0.05) on the 14th and 21st day after treatment, and the curative effect was more obvious (P <0.05 ). CONCLUSION: Compared with Xuebatongmo group and Xuesaitong group, the combination therapy of Ginkgo biloba and Xuesaitong can improve the neurological deficit (P <0.05) and improve the curative effect without any increase of bleeding side effects.